Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Belantamab mafodotin1件: Belantamab mafodotin (Belantamab mafodotin)1件: Belantamab mafodotin (Belantamab mafodotin, Belantamab mafodotin-blmf) 💬 10件: TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		14件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬2件: 28, 63 💬
2Belantamab mafodotin 1.0 mg/kg (12 weeks)1件: Belantamab mafodotin (Belantamab mafodotin)1件: Belantamab mafodotin (Belantamab mafodotin, Belantamab mafodotin-blmf) 💬 10件: TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		14件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬1件: 28 💬
3Belantamab mafodotin 1.4 mg/kg (12 weeks)1件: Belantamab mafodotin (Belantamab mafodotin)1件: Belantamab mafodotin (Belantamab mafodotin, Belantamab mafodotin-blmf) 💬 10件: TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		14件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬1件: 28 💬
4Belantamab mafodotin 1.9 mg/kg (12 weeks)1件: Belantamab mafodotin (Belantamab mafodotin)1件: Belantamab mafodotin (Belantamab mafodotin, Belantamab mafodotin-blmf) 💬 10件: TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		14件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬1件: 28 💬
5Belantamab mafodotin 1.9 mg/kg (8 weeks)1件: Belantamab mafodotin (Belantamab mafodotin)1件: Belantamab mafodotin (Belantamab mafodotin, Belantamab mafodotin-blmf) 💬 10件: TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		14件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬1件: 28 💬
6Belantamab mafodotin 2.5 mg/kg (8 weeks)1件: Belantamab mafodotin (Belantamab mafodotin)1件: Belantamab mafodotin (Belantamab mafodotin, Belantamab mafodotin-blmf) 💬 10件: TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		14件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬1件: 28 💬
7Belantamab mafodotin every 8 weeks or 12 weeks as determined by Part 1 recommended dosages1件: Belantamab mafodotin (Belantamab mafodotin)1件: Belantamab mafodotin (Belantamab mafodotin, Belantamab mafodotin-blmf) 💬 10件: TNFRSF17,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		14件: Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Intestinal immune network for IgA production, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬1件: 28 💬